Probiotics for gum health during treatment with braces
| ISRCTN | ISRCTN95085398 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN95085398 |
| Secondary identifying numbers | MBRU-IRB-2018-015 |
- Submission date
- 04/09/2018
- Registration date
- 01/04/2019
- Last edited
- 07/04/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Oral Health
Plain English summary of protocol
Background and study aims
The use of orthodontic appliances (braces) increases biofilm (bacteria) retention and may lead to periodontal (gum) deterioration. Probiotics have been suggested to be beneficial in preventing or treating gingival (gum) inflammation. The aim of this study is to assess the inflammatory changes in the periodontium (gums) of orthodontic patients taking probiotics compared to usual oral hygiene. Secondary aims include assessing plaque, side effects, patient-reported outcomes and salivary microbiome (bacteria).
Who can participate?
Orthodontic patients aged under 18
What does the study involve?
Participants are randomly allocated to one of two groups. Group 1 consume probiotic tablets together with regular oral hygiene, while individuals in Group 2 do not receive the probiotic supplements. Assessments take place at the start of the study and after 3 months, assessing plaque, gingivitis (gum inflammation), gingival bleeding, potential side effects and patient-reported outcomes. Saliva samples are collected for salivary microbiome tests.
What are the possible benefits and risks of participating?
Not provided at time of registration
Where is the study run from?
Mohammed Bin Rashid University of Medicine and Health Sciences (United Arab Emirates)
When is the study starting and how long is it expected to run for?
February 2018 to December 2020
Who is funding the study?
Mohammed Bin Rashid University of Medicine and Health Sciences (United Arab Emirates)
Who is the main contact?
Dr Eleftherios Kaklamanos
Contact information
Scientific
Mohammed Bin Rashid University of Medicine and Health Sciences
Building 14, Dubai Healthcare City
Dubai
P.O Box 505055
United Arab Emirates
 ORCID ID |
0000-0002-0513-5110 |
|---|
Study information
| Study design | Single-center single-blind (to clinical and laboratory examiner) parallel-group randomized controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised parallel trial |
| Study setting(s) | Other |
| Study type | Prevention |
| Scientific title | A single-centre investigator-blinded randomized parallel-group study to investigate the effect of probiotic strains Streptococcus salivarius M18 and Lactobacillus acidophilus on gingival health of paediatric patients undergoing treatment with fixed orthodontic appliances |
| Study objectives | Gingival bleeding on probing is less in orthodontic patients consuming probiotics in addition to regular oral hygiene, compared to patients practicing daily home oral hygiene alone. |
| Ethics approval(s) | Mohammed Bin Rashid University of Medicine and Health Sciences Institutional Review Board Date of approval: 04 June 2018 Reference number: MBRU-IRB-2018-015 |
| Health condition(s) or problem(s) studied | Gingivitis, malocclusion treatment |
| Intervention | Subjects will be randomized into 2 groups with the aid of a computer program: Intervention group: Probiotic tablet + Usual home oral hygiene [according to manufacturer instructions, the participants will chew two tablets once daily for 3 months] No Intervention group: Usual home oral hygiene Data recordings of all patients will take place at baseline and 3 months [end of study] by previously calibrated examiner blinded for the group assignment, assessing plaque, gingivitis, gingival bleeding, potential adverse effects and patient-reported outcomes. Moreover, at baseline and 3-month examinations [end of study], whole saliva samples will be collected for salivary microbiome determination. |
| Intervention type | Supplement |
| Primary outcome measure | Gingival bleeding on probing: percentage of the buccal mesial, midline and distal sites from second premolar to second premolar which bleed upon probing, using the criteria for bleeding of the Gingival Index (Löe and Silness, 1963) at baseline and 3 months |
| Secondary outcome measures | Measured at baseline and 3 months: 1. Gingival Index assessed on the buccal surfaces from second premolar to second premolar (Löe and Silness, 1963) 2. Plaque Index modified (Clerehugh et al., 1998) 3. Potential adverse effects: inspection of the hard and soft oral cavity tissues and self-reported 4. Patient-reported outcomes (adapted from Herrera et al., 2017) |
| Overall study start date | 01/02/2018 |
| Completion date | 31/12/2020 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Upper age limit | 18 Years |
| Sex | Both |
| Target number of participants | 50 (allowing for dropouts) |
| Key inclusion criteria | 1. Healthy individuals, aged under 18 years, planned for simultaneous full arch upper and lower fixed labial orthodontic appliance therapy from second premolar to second premolar 2. In good general health 3. Have a dental history that includes brushing at least once a day 4. Willing and able to comply with the trial regime 5. Normal anatomical periodontal attachment 6. Gingival bleeding on probing on at least 30% of the buccal mesial, midline and distal sites of the teeth examined using the criteria for bleeding of the Gingival Index (Löe and Silness, 1963). |
| Key exclusion criteria | 1. Inability to make informed consent 2. Allergies, sensitivities or food intolerance 3. Presence of any congenital syndromes of the head and neck 4. Medical contraindications such as heart condition, immucompromised state or diseases necessitating antibiotic cover prior to procedures, use of immunosuppressants, 5. History of surgery within the past year or planned within the next 90 days 6. Severe nausea, fever, vomiting, bloody diarrhea or severe abdominal pain within the past one month 7. Presence of special physical or mental needs that would compromise manual dexterity 8. Chronic use of medications of any kind, probiotics or food supplements of any kind 9. Use of antibiotics, anti-inflammatory, steroids or hormones within one month from the start of the study. 10. Oral prophylaxis within one month from the start of the study. 11. Use of antibacterial mouthrinses or toothpastes with supplementary antibacterial agents. 12. Poor compliance with oral hygiene regimens 13. Poor periodontal health such as presence of supragingival calculus, subgingival calculus or periodontal pocketing 14. Extensive dental restorations or uncontrolled caries activity 15. Pregnancy, smokers 16. Planned use of premolar bands |
| Date of first enrolment | 15/09/2019 |
| Date of final enrolment | 30/03/2020 |
Locations
Countries of recruitment
- United Arab Emirates
Study participating centre
PO Box 505055
Dubai
PO Box 505055
United Arab Emirates
Sponsor information
University/education
Building 34, Dubai Healthcare City
Dubai
PO Box 505055
United Arab Emirates
| Website | https://www.mbruniversity.ac.ae |
|---|---|
"ROR" |
https://ror.org/05g48k331 |
Funders
Funder type
University/education
No information available
Results and Publications
| Intention to publish date | 31/07/2021 |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Data sharing statement to be made available at a later date |
| Publication and dissemination plan | Additional study documents will be available upon request. Presentations in congresses and publication in peer-reviewed articles. |
| IPD sharing plan | The data sharing plans for the current study are unknown and will be made available at a later date. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol article | protocol | 08/09/2019 | 01/11/2019 | Yes | No |
Editorial Notes
07/04/2020: The following changes have been made:
1. The overall trial end date has been changed from 31/03/2020 to 31/12/2020.
2. The intention to publish date has been changed from 30/09/2020 to 31/07/2021.
3. The plain English summary has been updated to reflect the changes above.
01/11/2019: The following changes were made to the trial record:
1. The recruitment start date was changed from 01/04/2019 to 15/09/2019.
2. Publication reference added.
